Edition:
India

Yestar Healthcare Holdings Co Ltd (2393.HK)

2393.HK on Hong Kong Stock

3.28HKD
15 Dec 2017
Change (% chg)

HK$-0.09 (-2.67%)
Prev Close
HK$3.37
Open
HK$3.37
Day's High
HK$3.40
Day's Low
HK$3.25
Volume
897,500
Avg. Vol
848,532
52-wk High
HK$4.20
52-wk Low
HK$3.10

Latest Key Developments (Source: Significant Developments)

Yestar International says in pre-stage of considering possible acquisitions
Friday, 14 Oct 2016 

Yestar International Holdings Company Ltd <2393.HK> : Is in a preliminary stage of considering feasibility of possible acquisitions of equity interest in various medical device companies .No definitive legally binding agreement or contract has been entered into by company.  Full Article

Yestar International updates on share transfer agreement
Thursday, 13 Oct 2016 

Yestar International Holdings Company Ltd <2393.HK>: Purchaser, vendors and target company entered into share transfer agreement . Yestar international holdings company ltd - deal for consideration of rmb336 million . Yestar international holdings company - consideration is to be satisfied by cash by way of internal cash resources and/or available banking facilities. .Yestar international holdings - transaction in relation to acquisition of 70% equity interest in guangzhou hongen medical diagnostic technologies co.  Full Article

Yestar International issues positive profit alert<2393.HK>
Monday, 1 Aug 2016 

Yestar International Holdings Co Ltd <2393.HK>: Positive profit alert . Expected to record increase of not less than 80% in its consolidated net profit for six months ended 30 June 2016 . Expected to record increase of not less than 55% in consolidated net profit attributable to owners of parent for HY .Positive profit mainly attributable to outstanding performance of in vitro diagnostic business with high profit margin.  Full Article

Yestar International says in early stages of equity interest acquisition of medical device co<2393.HK>
Monday, 30 May 2016 

Yestar International Holdings Co Ltd <2393.HK>: Possible acquisition <2393.HK> . Company is in a preliminary stage of considering the feasibility of an acquisition . Acquisition of equity interest in a medical device company in the people's republic of China from an independent third party. . As at the date of announcement, no definitive legally binding agreement or contract has been entered into by co .  Full Article